학술논문

Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
Document Type
Article
Source
Clinical, Cosmetic & Investigational Dermatology; Dec2023, Vol. 16, p3561-3574, 14p
Subject
DRUG efficacy
PSORIASIS
QUALITY of life
Language
ISSN
11787015
Abstract
Copyright of Clinical, Cosmetic & Investigational Dermatology is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)